The results confirmed that the protein and RNA expression levels of α-SMA and collagen I in the lung tissues of the remdesivir group were significantly lower than those in the BLM model group and better than those of the positive control group (Figures 9A,B). The gene discussed is ACTA1; the disease is Bloom syndrome.